Data shows ‘incomprehensible price rises’ Related items from OnMedica 75% of reappraised CDF drugs approved for NHS Rising costs of generic medications Pfizer fined a record £84.2m for overcharging NHS cancer patients still denied treatments available in other countries Study shows huge global variation in cancer drug costs |
No comments:
Post a Comment